XL335 | CAS:629664-81-9

• 価格
• 構造式
• 製品情報
• 製品詳細
• 文献

価格

目次に戻る

構造式

目次に戻る

製品情報

XL335 is an orally bioavailable and potent agonist of the farnesoid X receptor (FXR) with an EC₅₀ value of 4 nM in CV-1 cells transfected with human FXR. It is selective for FXR over a panel of 15 nuclear receptors at concentrations up to 10 μM. XL335 induces expression of mouse intestinal bile acid binding protein (IBABP), human bile salt excretory pump (BSEP), and small heterodimer partner (SHP) genes in reporter gene assays. It also induces a 20-, 13-, and 2-fold increase in mRNA expression for IBABP, BSEP, and SHP, respectively, at a concentration of 1 μM. XL335 (3 mg/kg) reduces plasma cholesterol and triglycerides by 39 and 50%, respectively, and decreases the area of pre-atherosclerotic lesions in LDLR^-/- mice fed a Western diet. It also decreases hepatic fibrosis in a mouse model of non-alcoholic steatohepatitis.

目次に戻る

製品詳細

name	XL335
Formal Name	3-(3,4-difluorobenzoyl)-1,2,3,6-tetrahydro-1,1-dimethyl-azepino[4,5-b]indole-5-carboxylic acid, 1-methylethyl ester
CAS Number	629664-81-9
Synonyms	FXR 450 Turofexorate Isopropyl WAY-362450
Molecular Formula	C25H24F2N2O3
Formula Weight	438.5
Purity	≥98%
Formulation	A crystalline solid
λmax	216, 262, 340 nm
SMILES	O=C(OC(C)C)C1=CN(C(C2=CC(F)=C(F)C=C2)=O)CC(C)(C)C3=C1NC4=C3C=CC=C4
InChI Code	InChI=1S/C25H24F2N2O3/c1-14(2)32-24(31)17-12-29(23(30)15-9-10-18(26)19(27)11-15)13-25(3,4)21-16-7-5-6-8-20(16)28-22(17)21/h5-12,14,28H,13H2,1-4H3
InChI Key	INASOKQDNHHMRE-UHFFFAOYSA-N
Storage	-20°C
Shipping	Room temperature in continental US; may vary elsewhere
Stability	≥ 2 years

目次に戻る

文献

1. Flatt, B., Martin, R., Wang, T.L., et al. Discovery of XL335 (WAY-362450), a highly potent, selective, and orally active agonist of the farnesoid X receptor (FXR). J. Med. Chem. 52(4), 904-907 (2009).

2. Zhang, S., Wang, J., Liu, Q., et al. Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis. J. Hepatol. 51(2), 380-388 (2009).

目次に戻る